These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31767150)

  • 1. Doxorubicin inhibits PD-L1 expression by enhancing TTP-mediated decay of PD-L1 mRNA in cancer cells.
    Kim DJ; Jang JH; Ham SY; Choi SH; Park SS; Jeong SY; Kim BC; Jeon DY; Lee BJ; Ko BK; Park JW; Cho WJ
    Biochem Biophys Res Commun; 2020 Feb; 522(2):402-407. PubMed ID: 31767150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tristetraprolin Overexpression in Gastric Cancer Cells Suppresses PD-L1 Expression and Inhibits Tumor Progression by Enhancing Antitumor Immunity.
    Guo J; Qu H; Shan T; Chen Y; Chen Y; Xia J
    Mol Cells; 2018 Jul; 41(7):653-664. PubMed ID: 29936792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3'UTR AU-Rich Elements (AREs) and the RNA-Binding Protein Tristetraprolin (TTP) Are Not Required for the LPS-Mediated Destabilization of Phospholipase-Cβ-2 mRNA in Murine Macrophages.
    Shukla S; Elson G; Blackshear PJ; Lutz CS; Leibovich SJ
    Inflammation; 2017 Apr; 40(2):645-656. PubMed ID: 28124257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tristetraprolin suppresses AHRR expression through mRNA destabilization.
    Lee HH; Kim WT; Kim DH; Park JW; Kang TH; Chung JW; Leem SH
    FEBS Lett; 2013 May; 587(10):1518-23. PubMed ID: 23583445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase.
    Sanduja S; Kaza V; Dixon DA
    Aging (Albany NY); 2009 Sep; 1(9):803-17. PubMed ID: 20157568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tristetraprolin down-regulates IL-23 expression in colon cancer cells.
    Lee HH; Yang SS; Vo MT; Cho WJ; Lee BJ; Leem SH; Lee SH; Cha HJ; Park JW
    Mol Cells; 2013 Dec; 36(6):571-6. PubMed ID: 24292977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA.
    Coelho MA; de Carné Trécesson S; Rana S; Zecchin D; Moore C; Molina-Arcas M; East P; Spencer-Dene B; Nye E; Barnouin K; Snijders AP; Lai WS; Blackshear PJ; Downward J
    Immunity; 2017 Dec; 47(6):1083-1099.e6. PubMed ID: 29246442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tristetraprolin-RNA interaction map reveals a novel TTP-RelB regulatory network for innate immunity gene expression.
    Tu Y; Wu X; Yu F; Dang J; Wei Y; Yu H; Liao W; Zhang Y; Wang J
    Mol Immunol; 2020 May; 121():59-71. PubMed ID: 32163759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tristetraprolin controls the stability of cIAP2 mRNA through binding to the 3'UTR of cIAP2 mRNA.
    Kim CW; Kim HK; Vo MT; Lee HH; Kim HJ; Min YJ; Cho WJ; Park JW
    Biochem Biophys Res Commun; 2010 Sep; 400(1):46-52. PubMed ID: 20691152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tristetraprolin activation by resveratrol inhibits the proliferation and metastasis of colorectal cancer cells.
    Lee SR; Jin H; Kim WT; Kim WJ; Kim SZ; Leem SH; Kim SM
    Int J Oncol; 2018 Sep; 53(3):1269-1278. PubMed ID: 29956753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tristetraprolin down-regulates IL-17 through mRNA destabilization.
    Lee HH; Yoon NA; Vo MT; Kim CW; Woo JM; Cha HJ; Cho YW; Lee BJ; Cho WJ; Park JW
    FEBS Lett; 2012 Jan; 586(1):41-6. PubMed ID: 22138182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttranscriptional regulation of IL-23 expression by IFN-gamma through tristetraprolin.
    Qian X; Ning H; Zhang J; Hoft DF; Stumpo DJ; Blackshear PJ; Liu J
    J Immunol; 2011 Jun; 186(11):6454-64. PubMed ID: 21515794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tristetraprolin regulates TNF TNF-alpha mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways.
    Deleault KM; Skinner SJ; Brooks SA
    Mol Immunol; 2008 Jan; 45(1):13-24. PubMed ID: 17606294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tristetraprolin regulates interleukin-6 expression through p38 MAPK-dependent affinity changes with mRNA 3' untranslated region.
    Zhao W; Liu M; D'Silva NJ; Kirkwood KL
    J Interferon Cytokine Res; 2011 Aug; 31(8):629-37. PubMed ID: 21457063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bi-phased regulation of the post-transcriptional inflammatory response by Tristetraprolin levels.
    Mahmoud L; Moghrabi W; Khabar KSA; Hitti EG
    RNA Biol; 2019 Mar; 16(3):309-319. PubMed ID: 30664390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tristetraprolin regulates prostate cancer cell growth through suppression of E2F1.
    Lee HH; Lee SR; Leem SH
    J Microbiol Biotechnol; 2014 Feb; 24(2):287-94. PubMed ID: 24150491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-inflammatory cytokines reduce human TAFI expression via tristetraprolin-mediated mRNA destabilisation and decreased binding of HuR.
    Komnenov D; Scipione CA; Bazzi ZA; Garabon JJ; Koschinsky ML; Boffa MB
    Thromb Haemost; 2015 Aug; 114(2):337-49. PubMed ID: 26062599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hu antigen R and tristetraprolin: counter-regulators of rat apical sodium-dependent bile acid transporter by way of effects on messenger RNA stability.
    Chen F; Shyu AB; Shneider BL
    Hepatology; 2011 Oct; 54(4):1371-8. PubMed ID: 21688286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay.
    Ogilvie RL; Abelson M; Hau HH; Vlasova I; Blackshear PJ; Bohjanen PR
    J Immunol; 2005 Jan; 174(2):953-61. PubMed ID: 15634918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells.
    Bourcier C; Griseri P; Grépin R; Bertolotto C; Mazure N; Pagès G
    Am J Physiol Cell Physiol; 2011 Sep; 301(3):C609-18. PubMed ID: 21593445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.